• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定期摄入含约氏乳杆菌的发酵乳对幽门螺杆菌相关性胃炎的有益作用。

Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis.

作者信息

Pantoflickova D, Corthésy-Theulaz I, Dorta G, Stolte M, Isler P, Rochat F, Enslen M, Blum A L

机构信息

Division of Gastroenterology, University Hospital, Lausanne, Switzerland.

出版信息

Aliment Pharmacol Ther. 2003 Oct 15;18(8):805-13. doi: 10.1046/j.1365-2036.2003.01675.x.

DOI:10.1046/j.1365-2036.2003.01675.x
PMID:14535874
Abstract

BACKGROUND

Lactobacillus johnsonii (Lj1) had an in vitro and in vivo inhibitory effect on Helicobacter pylori. Fermented milk containing Lj1 (LC1), coadministered with antibiotics had a favourable effect on H. pylori gastritis.

AIM

Evaluate the effect of LC1 intake without antibiotics on H. pylori gastritis.

METHODS

Fifty H. pylori positive healthy volunteers were randomised in a double-blind study to LC1 or placebo. Gastric biopsies from the antrum and corpus were obtained before, and after 3 and 16 weeks of treatment, for histology and quantitative cultures.

RESULTS

Severity and activity of antral gastritis was reduced after 16-week LC1 intake (pretreatment and 16-week inflammatory cell score: 6.0 +/- 0.8 vs. 5.3 +/- 0.1; P=0.04). H. pylori density decreased in the antrum after LC1 intake (3-week: 4.4 +/- 0.6; 16-week: 4.3 +/- 0.5 log10 colony forming units (cfu) vs. pretreatment 4.5 +/- 0.4 log10 cfu; P=0.04, respectively). Mucus thickness increased after 16 weeks of LC1 consumption (change of mucus thickness with LC1 and placebo in the antrum: 0.6 +/- 1.3 vs. -0.2 +/- 1.0, P=0.01; in the corpus: 0.3 +/- 1.1 vs. -0.6 +/- 1.5, P=0.03).

CONCLUSION

LC1 intake had a favourable, albeit weak, effect on H. pylori associated gastritis, particularly in the antrum. Regular ingestion of fermented milk containing L. johnsonii may reduce the risk of developing disorders associated with high degrees of gastric inflammation and mucus depletion.

摘要

背景

约氏乳杆菌(Lj1)在体外和体内对幽门螺杆菌均有抑制作用。含Lj1的发酵乳(LC1)与抗生素联合使用对幽门螺杆菌性胃炎有良好效果。

目的

评估在不使用抗生素的情况下摄入LC1对幽门螺杆菌性胃炎的影响。

方法

50名幽门螺杆菌阳性的健康志愿者被随机纳入一项双盲研究,分为LC1组或安慰剂组。在治疗前、治疗3周和16周后,采集胃窦和胃体的胃活检组织进行组织学检查和定量培养。

结果

摄入LC1 16周后,胃窦胃炎的严重程度和活动性降低(治疗前和16周时炎症细胞评分:6.0±0.8 vs. 5.3±0.1;P=0.04)。摄入LC1后,胃窦中幽门螺杆菌密度降低(3周时:4.4±0.6;16周时:4.3±0.5 log10菌落形成单位(cfu),而治疗前为4.5±0.4 log10 cfu;P分别为0.04)。摄入LC1 16周后,黏液厚度增加(胃窦中LC1组和安慰剂组黏液厚度变化:0.6±1.3 vs. -0.2±1.0,P=0.01;胃体中:0.3±1.1 vs. -0.6±1.5,P=0.03)。

结论

摄入LC1对幽门螺杆菌相关性胃炎有良好作用,尽管作用较弱,尤其是在胃窦。定期摄入含约氏乳杆菌的发酵乳可能会降低发生与高度胃炎症和黏液减少相关疾病的风险。

相似文献

1
Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis.定期摄入含约氏乳杆菌的发酵乳对幽门螺杆菌相关性胃炎的有益作用。
Aliment Pharmacol Ther. 2003 Oct 15;18(8):805-13. doi: 10.1046/j.1365-2036.2003.01675.x.
2
Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.酸化乳(LC-1)对人类幽门螺杆菌胃炎的有益作用。
Eur J Gastroenterol Hepatol. 2001 Jan;13(1):25-9. doi: 10.1097/00042737-200101000-00005.
3
Reduction of overall Helicobacter pylori colonization levels in the stomach of Mongolian gerbil by Lactobacillus johnsonii La1 (LC1) and its in vitro activities against H. pylori motility and adherence.约氏乳杆菌La1(LC1)对蒙古沙鼠胃中幽门螺杆菌总体定植水平的降低作用及其对幽门螺杆菌运动性和黏附性的体外活性。
Biosci Biotechnol Biochem. 2012;76(4):850-2. doi: 10.1271/bbb.110921. Epub 2012 Apr 7.
4
Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety.抑酸治疗期间幽门螺杆菌相关性胃体胃炎的增加:对长期安全性的影响
Am J Gastroenterol. 1995 Sep;90(9):1401-6.
5
Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans.嗜酸乳杆菌(约氏乳杆菌)La1的乳清基培养上清液对人类幽门螺杆菌感染的影响。
Digestion. 1999;60(3):203-9. doi: 10.1159/000007660.
6
Treatment with a proton pump inhibitor promotes corpus gastritis in patients with Helicobacter pylori-infected antrum-predominant gastritis.使用质子泵抑制剂治疗会促使幽门螺杆菌感染的以胃窦为主的胃炎患者发生胃体胃炎。
Aliment Pharmacol Ther. 2002 Jan;16(1):159-65. doi: 10.1046/j.1365-2036.2002.01147.x.
7
Relation between IgG and IgA antibody titres against Helicobacter pylori in serum and severity of gastritis in asymptomatic subjects.无症状受试者血清中抗幽门螺杆菌IgG和IgA抗体滴度与胃炎严重程度的关系。
J Clin Pathol. 1994 Mar;47(3):227-31. doi: 10.1136/jcp.47.3.227.
8
Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial.长期使用奥美拉唑治疗的反流性食管炎患者幽门螺杆菌感染的治愈可逆转胃炎且不会加重反流性疾病:一项随机对照试验的结果
Gut. 2004 Jan;53(1):12-20. doi: 10.1136/gut.53.1.12.
9
Helicobacter heilmannii gastritis: association with acid peptic diseases and comparison with Helicobacter pylori gastritis.海尔曼螺杆菌胃炎:与酸相关性疾病的关联及与幽门螺杆菌胃炎的比较
Mod Pathol. 1999 May;12(5):534-8.
10
Prevalence and pattern of Helicobacter pylori gastritis in the gastric cardia.胃贲门部幽门螺杆菌胃炎的患病率及模式
Am J Gastroenterol. 1997 Dec;92(12):2220-4.

引用本文的文献

1
Unveiling the potential of in digestive diseases: a comprehensive review.揭示[具体内容]在消化系统疾病中的潜力:一项综述。 (注:原文中“in digestive diseases”前缺失具体所指内容)
Front Microbiol. 2025 Aug 1;16:1508382. doi: 10.3389/fmicb.2025.1508382. eCollection 2025.
2
Effects of Lactobacillus spp. on Helicobacter pylori: A Promising Frontier in the Era of Antibiotic Resistance.乳酸杆菌属对幽门螺杆菌的影响:抗生素耐药时代的一个有前景的前沿领域。
Probiotics Antimicrob Proteins. 2024 Nov 5. doi: 10.1007/s12602-024-10396-z.
3
Beneficial Effect of Heat-Killed Lactic Acid Bacterium No. 1088 on Temporal Gastroesophageal Reflux-Related Symptoms in Healthy Volunteers: A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study.
热灭活乳酸菌1088对健康志愿者暂时性胃食管反流相关症状的有益作用:一项随机、安慰剂对照、双盲、平行组研究。
Nutrients. 2024 Apr 20;16(8):1230. doi: 10.3390/nu16081230.
4
The Effects of on Diseases and Its Potential Applications.关于……对疾病的影响及其潜在应用。 (原文中“on”前面缺少具体内容)
Microorganisms. 2023 Oct 17;11(10):2580. doi: 10.3390/microorganisms11102580.
5
Microbiota in the stomach and application of probiotics to gastroduodenal diseases.胃中的微生物群及益生菌在胃十二指肠疾病中的应用。
World J Gastroenterol. 2022 Dec 21;28(47):6702-6715. doi: 10.3748/wjg.v28.i47.6702.
6
Lactobacillus spp. for Gastrointestinal Health: Current and Future Perspectives.用于胃肠道健康的乳杆菌属:当前和未来的观点。
Front Immunol. 2022 Apr 6;13:840245. doi: 10.3389/fimmu.2022.840245. eCollection 2022.
7
Probiotics and their Metabolites Reduce Oxidative Stress in Middle-Aged Mice.益生菌及其代谢产物可降低中年小鼠的氧化应激。
Curr Microbiol. 2022 Feb 14;79(4):104. doi: 10.1007/s00284-022-02783-y.
8
Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections.益生菌作为对抗幽门螺杆菌胃部感染的活体微生物战士。
BMC Gastroenterol. 2021 Oct 20;21(1):388. doi: 10.1186/s12876-021-01977-1.
9
Detection of Antimicrobial Resistance of Bacteria Isolated from Sheep's Milk and Cheese.从羊奶和奶酪中分离出的细菌的抗菌药物耐药性检测
Antibiotics (Basel). 2021 May 12;10(5):570. doi: 10.3390/antibiotics10050570.
10
The efficacy and safety of Clostridium butyricum and Bacillus coagulans in Helicobacter pylori eradication treatment: An open-label, single-arm pilot study.丁酸梭菌和凝结芽孢杆菌在幽门螺杆菌根除治疗中的疗效和安全性:一项开放标签、单臂试点研究。
Medicine (Baltimore). 2020 Nov 6;99(45):e22976. doi: 10.1097/MD.0000000000022976.